San Diego-centered Viking Therapeutics marked alone as a serious competitor within the weight loss drug marketplace in February just after revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered like a weekly injection and in March the com